Livingston, NJ, USA — The SyncroPatch 384/768PE offers the highest throughput in automated patch clamping history. The SyncroPatch 384/768PE focuses on providing both high quality recordings together with broad experimental versatility, two important hallmarks that clearly convinced scientific researchers at the Northwestern University Feinberg School of Medicine, Chicago, IL. The SyncroPatch 384/768PE is an advanced […]

Cambridge, UK — BioSilta Ltd, a developer of advanced, reagent-based microbial growth systems, today announced the signing of a non-exclusive worldwide distribution agreement with Sigma-Aldrich®(Nasdaq: SIAL). Research scientists now have the option of ordering BioSilta’s EnPresso® growth systems for microbial cell cultures through global supplier Sigma-Aldrich. BioSilta’s lead product range, EnPresso B growth systems, offer […]

Billerica, MA -– Seahorse Bioscience and the University of Alabama at Birmingham (UAB) announced today that they have entered into a partnership to study the bioenergetic health of cells in cryo-preserved blood – a step that will ultimately produce a first-of-its-kind clinical test of metabolic bioenergetic health. Because cutting-edge work is now being done on […]

BOTHELL, WA — — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today provided an update on use of the Company’s HypoThermosol storage/shipping media and CryoStor cryopreservation freeze media […]

Billingham, Teesside, UK and Research Triangle Park, NC, USA -– FUJIFILM Diosynth Biotechnologies has announced the launch of its new mammalian expression platform, which it has named ‘Apollo™’. The platform is designed to create a robust ‘manufacturing-ready’ cell line and consists of four key components: a new CHO DG44-derived host cell line; a novel expression […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it disclosed on October 3, 2014, through which BioTime received $29,425,961 and certain subsidiaries received approximately $1,558,905 from the sale of BioTime common shares. BioTime and the subsidiaries intend to use the net proceeds from their sales to […]

Ann Arbor, MI – Essen BioScience, Inc. (“Essen” or the Company), a leading provider of critical analytical instrumentation, software, reagents and services used in cell-based life science research, is pleased to announce that Brett Williams will succeed Kirk Schroeder as President of the Company. Mr. Schroeder will continue with the business as VP of Research […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT:BTX) announced today that Michael H. Mulroy and Stephen L. Cartt are joining its Board of Directors. Mr. Mulroy has been appointed to the Board to fill a vacancy and Mr. Cartt has been nominated for election to the Board at the Company’s upcoming annual shareholders’ meeting, which will […]

FAIRFIELD, CT. –– GE Chairman and CEO Jeff Immelt announced today the appointment of John Flannery as president and CEO of GE Healthcare succeeding John Dineen, who is leaving GE. The appointment is effective immediately. Flannery, 53, most recently was senior vice president of business development for GE. In the past year, Flannery led business […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT:BTX) today announced that it has agreed to sell up to an aggregate of 9,431,398 common shares, in a registered direct offering at an offering price of $3.12 per share. The price per share was the closing price of our common shares on the NYSE MKT on October 2, […]